Arruzazabala ML, Valdes S, Mas R, et al. Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers.
Pharmacol Res.
1996;34:181 - 185.
Arruzazabala ML, Mas R, Molina V, et al. Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients.
Int J Tissue React.
1998;20:119 - 124.
Carbajal D, Arruzazabala ML, Valdes S, et al. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers.
Prostaglandins Leukot Essent Fatty Acids.
1998;58:61 - 64.
Castano G, Mas R, Arruzazabala M, et al. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Int J Clin Pharmacol Res.
1999;19:105 - 116.
Arruzazabala ML, Valdes S, Mas R, et al. Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers.
Pharmacol Res.
1997;36:293 - 297.
Arruzazabala ML, Molina V, Mas R, et al. Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.
Clin Exp Pharmacol Physiol.
2002;29:891 - 897.
Feigin VL, Doronin BM, Popova TF, et al. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
Eur J Neurol.
2001;8:81 - 85.
Bereczki D, Fekete I. Vinpocetine for acute ischaemic stroke.
Cochrane Database Syst Rev.
2000;(2):CD000480.
Lohmann A, Dingler E, Sommer W, et al. Bioavailability of vinpocetine and interference of the time of application with food intake.
Arzneimittelforschung.
1992;42:914 - 917.
Bonoczk P, Panczel G, Nagy Z. Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study.
Eur J Ultrasound.
2002;15:85 - 91.
Gusev EI, Skvortsova VI, Dambinova SA, et al. Neuroprotective effects of glycine for therapy of acute ischaemic stroke.
Cerebrovasc Dis.
2000;10:49 - 60.
Sopala M, Schweizer S, Schafer N, et al. Neuroprotective activity of a nanoparticulate formulation of the glycineB site antagonist MRZ 2/576 in transient focal ischaemia in rats.
Arzneimittelforschung.
2002;52:168 - 174.
Tatlisumak T, Takano K, Meiler MR, et al. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Acta Neurochir Suppl.
2000;76:331 - 333.
Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women.
JAMA.
2001;285:304 - 312.
Marchioli R, Schweiger C, Tavazzi L, et al. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lipids.
2001;36 (suppl):S119 - S126.
Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
N Engl J Med.
2000;342:154 - 160.
Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice.
Lancet.
2001;357:89 - 95.
Leppala JM, Virtamo J, Fogelholm R, et al. Vitamin E and beta carotene supplementation in high risk for stroke. A subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Arch Neurol.
2000;57:1503 - 1509.
Krivoy N, Pavlotzky E, Chrubasik S, et al. Effect of Salicic cortex extract on human platelet aggregation.
Planta Med.
2000;66:1 - 4.
Gosman-Hedstrom G, Claesson L, Klingenstierna U, et al. Effects of acupuncture treatment on daily life activities and quality of life: a controlled, prospective, and randomized study of acute stroke patients.
Stroke.
1998;29:2100A - 2108.
Johansson BB, Haker E, von Arbin M, et al. Acupuncture and transcutaneous nerve stimulation in stroke rehabilitation: a randomized, controlled trial.
Stroke.
2001;32:707 - 713.
Sze FK, Wong E, Yi X, et al. Does acupuncture have additional value to standard poststroke motor rehabilitation?
Stroke.
2002;33:186 - 194.
Naeser MA, Alexander MP, Stiassny-Eder D, et al. Real versus sham acupuncture in the treatment of paralysis in acute stroke patients: a CT scan lesion site study.
J Neuro Rehab.
1992;6:163 - 173.
Sallstrom S, Kjendahl A, Osten PE, et al. Acupuncture in the treatment of stroke patients in the subacute stage: a randomized, controlled study.
Complement Ther Med.
1996;4:193 - 197.
Kjendahl A, Sallstrom S, Osten PE, et al. A one year follow-up study on the effects of acupuncture in the treatment of stroke patients in the subacute stage: a randomized, controlled study.
Clin Rehabil.
1997;11:192 - 200.
Hu HH, Chung C, Liu TJ, et al. A randomized controlled trial on the treatment for acute partial ischemic stroke with acupuncture.
Neuroepidemiology.
1993;12:106 - 113.
Sempos CT, Looker AC, Gillum RE, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study.
Ann Epidemiol.
2000;10:441 - 448.
Davolos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction.
Neurology.
2000;54:1568 - 1574.
Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies.
Circulation.
1999;99:852 - 854.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
N Engl J Med.
2000;343:1833 - 1838.
Samenuk D, Link M, Homoud MK, et al. Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine.
Mayo Clin Proc.
2002;77:12 - 16.
Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use.
Neurology.
1993;43:1313 - 6.
Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink.
J Clin Psychopharmacol.
1997;17:437 - 439.
Lee MK, Cheng BW, Che CT, et al. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation.
Toxicol Sci.
2000;56:424 - 430.
Davalos A, Castillo J, Alvarez-Sabin J. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850 - 2857.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.